179 related articles for article (PubMed ID: 37975256)
1. Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells.
He J; Bugde P; Li J; Biswas R; Li S; Yang X; Tian F; Wu Z; Li Y
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975256
[TBL] [Abstract][Full Text] [Related]
2. Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells.
Hagmann W; Jesnowski R; Löhr JM
Neoplasia; 2010 Sep; 12(9):740-7. PubMed ID: 20824050
[TBL] [Abstract][Full Text] [Related]
3. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of SPARC-enhanced chemosensitivity of pancreatic cancer cells to gemcitabine].
Zhang J; Jiang H; Mao Z; Wang X; Fan X; Liu Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):335-40. PubMed ID: 25030587
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cancer cell growth in gemcitabine-resistant pancreatic carcinoma by mangiferin phytochemical involves induction of autophagy, endogenous ROS production, cell cycle disruption, mitochondrial mediated apoptosis and suppression of cancer cell migration and invasion.
Yu L; Chen M; Zhang R; Jin Z
J BUON; 2019; 24(4):1581-1586. PubMed ID: 31646812
[TBL] [Abstract][Full Text] [Related]
6. IFN‑γ induces apoptosis in gemcitabine‑resistant pancreatic cancer cells.
Kong X; Cheng D; Xu X; Zhang Y; Li X; Pan W
Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38488034
[TBL] [Abstract][Full Text] [Related]
7. Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model.
Humbert M; Castéran N; Letard S; Hanssens K; Iovanna J; Finetti P; Bertucci F; Bader T; Mansfield CD; Moussy A; Hermine O; Dubreuil P
PLoS One; 2010 Mar; 5(3):e9430. PubMed ID: 20209107
[TBL] [Abstract][Full Text] [Related]
8. The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine.
Yamaguchi M; Murata T; El-Rayes BF; Shoji M
Oncol Rep; 2015 Dec; 34(6):3304-10. PubMed ID: 26397991
[TBL] [Abstract][Full Text] [Related]
9. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
[TBL] [Abstract][Full Text] [Related]
10. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines.
Park SH; Sung JH; Kim EJ; Chung N
Braz J Med Biol Res; 2015 Feb; 48(2):111-9. PubMed ID: 25517919
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells.
Li Y; Revalde JL; Reid G; Paxton JW
Cancer Chemother Pharmacol; 2011 Sep; 68(3):603-10. PubMed ID: 21116627
[TBL] [Abstract][Full Text] [Related]
12. Enhanced gemcitabine cytotoxicity with knockdown of multidrug resistance protein genes in human cholangiocarcinoma cell lines.
Yang J; Sontag D; Gong Y; Minuk GY
J Gastroenterol Hepatol; 2021 Apr; 36(4):1103-1109. PubMed ID: 33002234
[TBL] [Abstract][Full Text] [Related]
13. Catechol enhances chemo‑ and radio‑sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells.
Moon JY; Ediriweera MK; Ryu JY; Kim HY; Cho SK
Oncol Rep; 2021 Mar; 45(3):1133-1141. PubMed ID: 33650657
[TBL] [Abstract][Full Text] [Related]
14. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.
Shi X; Liu S; Kleeff J; Friess H; Büchler MW
Oncology; 2002; 62(4):354-62. PubMed ID: 12138244
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.
Duong HQ; Hwang JS; Kim HJ; Kang HJ; Seong YS; Bae I
Int J Oncol; 2012 Sep; 41(3):855-61. PubMed ID: 22710732
[TBL] [Abstract][Full Text] [Related]
16. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
[TBL] [Abstract][Full Text] [Related]
17. Co-Delivery Using pH-Sensitive Liposomes to Pancreatic Cancer Cells: the Effects of Curcumin on Cellular Concentration and Pharmacokinetics of Gemcitabine.
Xu H; Li Y; Paxton JW; Wu Z
Pharm Res; 2021 Jul; 38(7):1209-1219. PubMed ID: 34189639
[TBL] [Abstract][Full Text] [Related]
18. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.
Jiang C; Yi XP; Shen H; Li YX
World J Gastroenterol; 2012 Jun; 18(23):2956-65. PubMed ID: 22736919
[TBL] [Abstract][Full Text] [Related]
19. Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells.
Shrikhande SV; Kleeff J; Kayed H; Keleg S; Reiser C; Giese T; Büchler MW; Esposito I; Friess H
Anticancer Res; 2006; 26(5A):3265-73. PubMed ID: 17094439
[TBL] [Abstract][Full Text] [Related]
20. Loss of runt-related transcription factor 3 induces gemcitabine resistance in pancreatic cancer.
Horiguchi S; Shiraha H; Nagahara T; Kataoka J; Iwamuro M; Matsubara M; Nishina S; Kato H; Takaki A; Nouso K; Tanaka T; Ichimura K; Yagi T; Yamamoto K
Mol Oncol; 2013 Aug; 7(4):840-9. PubMed ID: 23664167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
